.jpg?width=589&name=Gibco_BPI_banner%20(002).jpg)
Please join us for this free, live Ask the Expert webcast.
Just fill out the form below to register.
Presenters:
Chad Schwartz
Senior Global Product Manager for
Proprietary Cell Culture Media Formulations,
Proprietary Cell Culture Media Formulations,
Thermo Fisher Scientific
Eric Nalbach
Director of Product Management,
Bioproduction, Cell Culture Media,
Thermo Fisher Scientific
Chad Schwartz, PhD, is the Senior Global Product Manager for the Proprietary Cell Culture Media Formulations product line at Thermo Fisher Scientific. He earned his BS in both agricultural biotechnology and biology from the University of Kentucky in 2008 and his doctorate from that school's pharmaceutical sciences program in 2013. His dissertation focused on the mechanistic and biochemical studies of bacteriophage Φ29. In 2013, he became a postdoctoral scholar at the University of California, Davis, studying prostate cancer, making use of a number of cell culture methods and techniques, including cell line development and end-product optimization. In 2014, Chad became a Senior Application Scientist at Beckman Coulter, followed quickly by accepting a new role as Global Product Manager in Beckman's centrifugation business unit. Remaining with Danaher in 2018, Chad changed operating companies to Pall Corporation to take over management of Pall's filtration product lines and then assumed his current position at Thermo Fisher in early 2020. Chad has coauthored 13 publications and has provided many seminars at a number of scientific conferences and events.
Eric Nalbach has 21 years of experience in the development and manufacture of cell culture products. He is currently the Director of Product Management for bioproduction cell culture media at Thermo Fisher Scientific. During his 10 years with Thermo Fisher, Eric has contributed to the successful launch of pioneering products and technologies. He currently leads the media product management team, working with Operations to improve and expand global manufacturing capabilities, including Gibco™ (Advanced Granulation Technology) AGT™ facility operations in Paisley, Scotland. He graduated from Boston University with a degree in biochemistry and molecular biology and has worked in the biopharma industry in a variety of roles, from manufacturing with ImClone Systems (Eli Lilly) and Centocor (Janssen), to upstream processing with Laureate Pharma (Patheon), prior to his time with Thermo Fisher.
Eric Nalbach has 21 years of experience in the development and manufacture of cell culture products. He is currently the Director of Product Management for bioproduction cell culture media at Thermo Fisher Scientific. During his 10 years with Thermo Fisher, Eric has contributed to the successful launch of pioneering products and technologies. He currently leads the media product management team, working with Operations to improve and expand global manufacturing capabilities, including Gibco™ (Advanced Granulation Technology) AGT™ facility operations in Paisley, Scotland. He graduated from Boston University with a degree in biochemistry and molecular biology and has worked in the biopharma industry in a variety of roles, from manufacturing with ImClone Systems (Eli Lilly) and Centocor (Janssen), to upstream processing with Laureate Pharma (Patheon), prior to his time with Thermo Fisher.
